A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : iPSCs / induced pluripotent stem cells

[Related PubMed/MEDLINE]
Total Number of Papers: 5060
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   iPSCs  (>> Co-occurring Abbreviation)
Long Form:   induced pluripotent stem cells
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 3D-organoid culture supports differentiation of human CAR+ iPSCs into highly functional CAR T cells. CAR
2022 5-Aminolevulinate improves metabolic recovery and cell survival of the liver following cold preservation. 5-ALA, ESC, GS, HLCs
2022 A multiparametric calcium signal screening platform using iPSC-derived cortical neural spheroids. HTS
2022 A Novel UPLC-MS Metabolomic Analysis-Based Strategy to Monitor the Course and Extent of iPSC Differentiation to Hepatocytes. HLCs, PHHs
2022 A versatile and robust cell purification system with an RNA-only circuit composed of microRNA-responsive ON and OFF switches. miRNAs
2022 Accurate in silico simulation of the rabbit Purkinje fiber electrophysiological assay to facilitate early pharmaceutical cardiosafety assessment: Dream or reality? AP, DMTA
2022 Acellular nerve grafts supplemented with induced pluripotent stem cell-derived exosomes promote peripheral nerve reconstruction and motor function recovery. ANGs, SCs
2022 Advances in Allogeneic Cancer Cell Therapy and Future Perspectives on "Off-the-Shelf" T Cell Therapy Using iPSC Technology and Gene Editing. CTLs, GVHD
2022 Advances in Modeling Polyglutamine Diseases Using Genome Editing Tools. hESCs
10  2022 Advances in NK cell production. MHC, NK, PBMCs, UCB
11  2022 Advances in the application of induced pluripotent stem cells in Alzheimer's diseases and Parkinson's diseases. AD, PD
12  2022 An ACVR1 activating mutation causes neuropathic pain and sensory neuron hyperexcitability in humans. ACVR1, BMP, FOP, iSNs, QST
13  2022 An Integrated Approach to Studying Rare Neuromuscular Diseases Using Animal and Human Cell-Based Models. CMT
14  2022 Analysis of induced pluripotent stem cell clones derived from a patient with mosaic neurofibromatosis type 2. MNCs, NF2
15  2022 Applications of 3D Bioprinting Technology in Induced Pluripotent Stem Cells-Based Tissue Engineering. ---
16  2022 Are Induced Pluripotent Stem Cells a Step towards Modeling Pediatric Leukemias? ---
17  2022 Assessment of FDA-Approved Drugs as a Therapeutic Approach for Niemann-Pick Disease Type C1 Using Patient-Specific iPSC-Based Model Systems. 25-HC, NPC1, PCs
18  2022 Bone regeneration of induced pluripotent stem cells derived from peripheral blood cells in collagen sponge scaffolds. MNCs
19  2022 BrewerIX enables allelic expression analysis of imprinted and X-linked genes from bulk and single-cell transcriptomes. SNVs, XCI
20  2022 Cadaveric Stem Cells: Their Research Potential and Limitations. ADSCs, CaSCs, HSCs, MSCs, NSCs, PMI, RPCs
21  2022 Cell models for Down syndrome-Alzheimer's disease research. AD, APP, DS, Hsa21
22  2022 Chronic spinal cord injury functionally repaired by direct implantation of encapsulated hair-follicle-associated pluripotent (HAP) stem cells in a mouse model: Potential for clinical regenerative medicine. BMS, ESCs, HAP, NPCs, NSCs, PFM, SCI
23  2022 Combinatorial Approach of Binary Colloidal Crystals and CRISPR Activation to Improve Induced Pluripotent Stem Cell Differentiation into Neurons. BCCs, CRISPRa, cSAPs, PS, Si
24  2022 Comparative analysis of CI- and CIV-containing respiratory supercomplexes at single-cell resolution. NPCs, PLA
25  2022 Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis. ALS, ASOs, NIBS, PBA
26  2022 Connexin 43 Gene Ablation Does Not Alter Human Pluripotent Stem Cell Germ Lineage Specification. Cx, PSC
27  2022 Continuous human iPSC-macrophage mass production by suspension culture in stirred tank bioreactors. iPSC-Mac, STBRs
28  2022 Correction of a Factor VIII genomic inversion with designer-recombinases. ---
29  2022 CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells. CRISPRa
30  2022 CRISPR single base editing, neuronal disease modelling and functional genomics for genetic variant analysis: pipeline validation using Kleefstra syndrome EHMT1 haploinsufficiency. NGS, VUS
31  2022 Current Development, Obstacle and Futural Direction of Induced Pluripotent Stem Cell and Mesenchymal Stem Cell Treatment in Degenerative Retinal Disease. MSCs
32  2022 Current Progress in Vascular Engineering and Its Clinical Applications. CABG, CHD, TEVGs
33  2022 Current State and Issues of Regenerative Medicine for Rheumatic Diseases. EPCs, MSCs, SLE, SSc
34  2022 Deconvoluting the Cells of the Human Heart with iPSC Technology: Cell Types, Protocols, and Uses. ---
35  2022 Defective hematopoietic differentiation of immune aplastic anemia patient-derived iPSCs. AA, HSPCs, PB
36  2022 Development and characterization of cell models harbouring mtDNA deletions for in vitro study of Pearson syndrome. SLSMDs
37  2022 Differentiation of Human-Induced Pluripotent Stem Cells (hiPSCs) into Human Primordial Germ Cell-like Cells (hPGCLCs) In Vitro. hiPSCs, hPGCLCs
38  2022 Disease-associated mutations in topoisomerase IIβ result in defective NK cells. NK
39  2022 Distinctive Clinical and Pathologic Features of Immature Teratomas Arising from Induced Pluripotent Stem Cell-Derived Beta Cell Injection in a Diabetes Patient. ---
40  2022 Dopaminergic neurons derived from porcine induced pluripotent stem cell like cells function in the Lanyu pig model of Parkinson's disease. D18 NPs, MPTP, PD, piPSC-like cells
41  2022 DOT1L inhibition enhances pluripotency beyond acquisition of epithelial identity and without immediate suppression of the somatic transcriptome. DOT1L, DOT1Li
42  2022 Down-syndrome-induced senescence disrupts the nuclear architecture of neural progenitors. DS, NPCs
43  2022 Downregulating MFN2 Promotes the Differentiation of Induced Pluripotent Stem Cells into Mesenchymal Stem Cells through the PI3K/Akt/GSK-3β/Wnt Signaling Pathway. iPSC-MSCs, MSCs
44  2022 Downregulation of Odd-Skipped Related 2, a Novel Regulator of Epithelial-Mesenchymal Transition, Enables Efficient Somatic Cell Reprogramming. EMT, MET, Osr2, TGF-beta, uORF2
45  2022 Efficient generation of endothelial cells from induced pluripotent stem cells derived from a patient with peripheral arterial disease. AcLDL, BOECs, ECs, EPCs, PAD
46  2022 Electrophysiological responses to seizurogenic compounds dependent on E/I balance in human iPSC-derived cortical neural networks. E/I, MOA
47  2022 Enhanced Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood and Using Their Mesoderm Differentiation Ability to Regenerate Infarcted Myocardium. CiMS, CiMS-iPSCs, HDFs, hESCs
48  2022 Enriched Environment and Exercise Enhance Stem Cell Therapy for Stroke, Parkinson's Disease, and Huntington's Disease. EE, ESCs, HD, MSCs, NSCs, PD
49  2022 Erythroid Differentiation of Induced Pluripotent Stem Cells Co-cultured with OP9 Cells for Diagnostic Purposes. RBCs
50  2022 Establishment and characterization of an induced pluripotent stem cell line CPGHi004-A from peripheral blood mononuclear cells of a healthy adult. PBMCs, SCI
51  2022 Establishment of a developmental toxicity assay based on human iPSC reporter to detect FGF signal disruption. ---
52  2022 Establishment of induced pluripotent stem cell line (ZZUi033-A) of a male with a novel L1CAM missense mutation. L1CAM
53  2022 Establishment of the induced pluripotent stem cell line PLAFMCi006-A from peripheral blood mononuclear cells of polycystic kidney disease patients with PKD2 gene mutation. PKD
54  2022 Evolutionary insights into primate skeletal gene regulation using a comparative cell culture model. DE, MSCs
55  2022 Expanding homogeneous culture of human primordial germ cell-like cells maintaining germline features without serum or feeder layers. hPGCLCs, LTC-hPGCLCs, PGC, xrTestis
56  2022 Fast and Efficient Mouse Pluripotency Reprogramming Using a Chemically-Defined Medium. MEFs
57  2022 Functional genomics and the future of iPSCs in disease modeling. hiPSCs
58  2022 Functional Lactotrophs in Induced Adenohypophysis Differentiated From Human iPS Cells. AP, PRL, SFEB-q
59  2022 Generation an induced pluripotent stem cell line SXMUi001-A derived from a hemophilia B patient carries variant F9 c.223C>T(p.R75X). HB
60  2022 Generation and characterization of human induced pluripotent stem cells (iPSCs) from three individuals without age-related macular degeneration. AMD
61  2022 Generation and characterization of human induced pluripotent stem cells (iPSCs) from three patients with age-related macular degeneration carrying rare variants in the CFH gene. AMD, CFH
62  2022 Generation and characterization of human umbilical cord blood-derived induced pluripotent stem cells (KRIBBi005-A). RBC, UCB
63  2022 Generation and characterization of human-derived iPSC lines from one pair of dizygotic twins discordant for schizophrenia. DSM-IV, PBMCs, SCZ
64  2022 Generation and Gene Expression Profiles of Grevy's Zebra Induced Pluripotent Stem Cells. ---
65  2022 Generation of a gene corrected human isogenic iPSC line (CPGHi001-A-1) from a hearing loss patient with the TMC1 p.M418K mutation using CRISPR/Cas9. ---
66  2022 Generation of a human induced pluripotent stem cell line KUMi006 from a patient with multiple myeloma. hiPSC
67  2022 Generation of a human iPSC line CIPi001-A from a benign familial infantile epilepsy patient related 16p11.2 deletion. ---
68  2022 Generation of a tendon-like tissue from human iPS cells. iPSC-MSCs
69  2022 Generation of An Induced Pluripotent Stem Cell Line from Human Liver Fibroblasts from A Patient with Combined Hepatocellular-Cholangiocarcinoma. AFP, AP, CC, cHCC-CC, CK7, DKK1, EB, HCC, HLFs, PCR, SOX17
70  2022 Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling. cDC1s, cDC1s, DC3s, DCs, OP9-DL1
71  2022 Generation of Complex Syngeneic Liver Organoids from Induced Pluripotent Stem Cells to Model Human Liver Pathophysiology. ---
72  2022 Generation of homozygous Nav1.8 knock-out iPSC lines by CRISPR Cas9 genome editing to investigate a potential new antiarrhythmic strategy. ---
73  2022 Generation of human GAPDH knock-in reporter iPSC lines for stable expression of tdTomato in pluripotent and differentiated culture conditions. ---
74  2022 Generation of human induced pluripotent stem cells from cystic fibrosis patient carrying nonsense mutation (p.S308X) in CFTR gene. CF
75  2022 Generation of induced pluripotent stem cells (NIMHi004-A, NIMHi005-A and NIMHi006-A) from healthy individuals of Indian ethnicity with no mutation for Parkinson's disease related genes. PBMCs, PD
76  2022 Generation of inflammation-responsive astrocytes from glial progenitors derived from human pluripotent stem cells. GPCs
77  2022 Generation of iPSC line from urine cells of hemophilia A with F8 (p. R814X) mutation. HUCs
78  2022 Generation of iPSC-Derived Brain Organoids for Drug Testing and Toxicological Evaluation. ---
79  2022 Generation of male germ cells in vitro from the stem cells. ESCs, MSCs, SSCs
80  2022 Generation of NPHP1 knockout human pluripotent stem cells by a practical biallelic gene deletion strategy using CRISPR/Cas9 and ssODN. SSTR
81  2022 Generation of Sheep Induced Pluripotent Stem Cells With Defined DOX-Inducible Transcription Factors via piggyBac Transposition. DOX, ESCs, PSCs
82  2022 Generation of SIV-resistant T cells and macrophages from nonhuman primate induced pluripotent stem cells with edited CCR5 locus. MCM
83  2022 Generation of two induced pluripotent stem cell lines, GZHMCi009-A and GZHMCi010-A, derived from peripheral blood mononuclear cells of two SCA3 patients with 14/74 CAG repeats of the ATXN3 mutation. SCA3
84  2022 Generation of ultra-treatment-resistant schizophrenia patient-derived induced pluripotent stem cell line UJSi002-A. PBMCs
85  2022 Genetic correction of TRMU allele restored the mitochondrial dysfunction-induced deficiencies in iPSCs-derived hair cells of hearing-impaired patients. HC, OEP
86  2022 Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis. ALS, GWASs
87  2022 Healing of bone defects by induced pluripotent stem cell-derived bone marrow mesenchymal stem cells seeded on hydroxyapatite-zirconia. BMSCs, CCK-8, EPSCs, IHC, RT-PCR
88  2022 Hematopoietic Cells from Pluripotent Stem Cells: Hope and Promise for the Treatment of Inherited Blood Disorders. ---
89  2022 Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infection. ACE2, TMPRSS2
90  2022 Human induced pluripotent stem cells derived from a patient with a mutation of FBN1c.1858C > T (p. Pro620Ser). PBMC
91  2022 Human induced pluripotent stem cells display a similar mutation burden as embryonic pluripotent cells in vivo. ---
92  2022 Human induced pluripotent stem cells integrate, create synapses and extend long axons after spinal cord injury. SCI, sNPCs
93  2022 Human induced pluripotent stem cells: From cell origin, genomic stability and epigenetic memory to translational medicine. ---
94  2022 Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids. AD
95  2022 Identification of MAEL as a promoter for the drug resistance model of iPSCs derived from T-ALL. DEGs, RNAi, T-ALL, T-iPSCs
96  2022 iMyoblasts for ex vivo and in vivo investigations of human myogenesis and disease modeling. bMyoblasts
97  2022 Inducing somatic cells into pluripotent stem cells is an important platform to study the mechanism of early embryonic development. ---
98  2022 Inhibiting mitochondrial fission rescues degeneration in hereditary spastic paraplegia neurons. hESCs, HSPs, NF, PNs
99  2022 Insights into Human-Induced Pluripotent Stem Cell-Derived Astrocytes in Neurodegenerative Disorders. ---
100  2022 Integrated fibroblast growth factor signal disruptions in human iPS cells for prediction of teratogenic toxicity of chemicals. FGF